Home/Filings/8-K/0001213900-26-007216
8-K//Current report

Bluerock Acquisition Corp. 8-K

Accession 0001213900-26-007216

$BLRKCIK 0002081532other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:16 PM ET

Size

305.0 KB

Accession

0001213900-26-007216

Research Summary

AI-generated summary of this filing

Updated

Bluerock Acquisition Corp. Appoints Independent Director Ziv Conen

What Happened
Bluerock Acquisition Corp. announced on January 23, 2026 that its board appointed Ziv Conen as a Class II director, designated an independent director under Nasdaq rules. His term expires at the company’s second annual meeting of shareholders. The company entered into an indemnity agreement, a director letter agreement, and a joinder to its registration rights agreement with Mr. Conen in connection with his appointment.

Key Details

  • Appointment date: January 23, 2026; term ends at the Company’s second annual meeting.
  • Compensation: Mr. Conen will receive 35,000 Class B ordinary shares from the Sponsor.
  • Agreements: Company entered into an indemnity agreement (including expense advancement), a letter agreement similar to other directors/officers, and a joinder to the December 10, 2025 registration rights agreement.
  • Background: Since Sept 2021 Partner at New Era Capital Partners (early-stage tech investments); previously Associate Partner at McKinsey (2016–2021); served as a Major in Israel’s Unit 8200; holds an MBA from MIT and a B.Sc. in Computer Science.

Why It Matters
This adds an independent director with deep technology and cybersecurity investing experience to the board, which may influence oversight and strategic direction—especially on tech, AI, cloud and security topics. The equity grant and registration-rights joinder align him with Sponsor arrangements used at the IPO, and the indemnity agreement provides standard director protections. For investors, the change signals a board refresh and strengthens the Company’s governance profile under Nasdaq independence rules.